Yu Yan
0009-0003-9129-8032
Publication & Citation Trends
Publications
0 total
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C OA
Cited by 1
Semantic Scholar
Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity. OA
Cited by 15
Semantic Scholar
USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells OA
Cited by 12
Semantic Scholar
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C OA
Cited by 0
Semantic Scholar
Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy
Cited by 2
Semantic Scholar
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks OA
Cited by 0
Semantic Scholar
Management of chronic liver diseases and cirrhosis: current status and future directions OA
Cited by 10
Semantic Scholar
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B OA
Cited by 1
Semantic Scholar
Research Topics
Electrocatalysts for Energy Conversion
(5)
Adipokines, Inflammation, and Metabolic Diseases
(4)
Geographic Information Systems Studies
(4)
Data Management and Algorithms
(4)
Supercapacitor Materials and Fabrication
(3)
Affiliations
Agency for Science, Technology and Research
Shandong University of Technology
Ministry of Education
Nanjing University of Chinese Medicine
Harbin Normal University